Atlas Trials

Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.

Clinical trial NCT00399867 · COMPLETED

Trial details

NCT number
NCT00399867
Sponsor
Ludwig-Maximilians - University of Munich
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2005-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.